Rebamipide
- Generic Name
- Rebamipide
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H15ClN2O4
- CAS Number
- 90098-04-7
- Unique Ingredient Identifier
- LR583V32ZR
- Background
Rebamipide has been investigated for the treatment of Stomach Ulcer, Keratoconjunctivitis Sicca, and Gastric Adenoma and Early Gastric Cancer.
- Indication
主要用于胃溃疡，但不宜单独用于Hp感染。也用于改善胃炎及慢性胃炎急性加重期的胃黏膜病变（如糜烂、出血、充血、水肿等）。
- Associated Conditions
- Gastric Ulcer
- Associated Therapies
- -
Rebamipide in Patients With Active Rheumatoid Arthritis
- First Posted Date
- 2021-12-21
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- October 6 University
- Target Recruit Count
- 50
- Registration Number
- NCT05166304
- Locations
- 🇪🇬
Minia University, Minya, Egypt
Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy
- First Posted Date
- 2021-05-13
- Last Posted Date
- 2021-05-13
- Lead Sponsor
- Seoul National University Boramae Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT04885751
Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients
- Conditions
- Interventions
- First Posted Date
- 2020-12-02
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Cairo University
- Target Recruit Count
- 39
- Registration Number
- NCT04649697
- Locations
- 🇪🇬
Cairo University, Cairo, Egypt
h.Pylori Ttt With Rebamipide
- Conditions
- First Posted Date
- 2020-09-16
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 60
- Registration Number
- NCT04550858
Comparison Between Rebamipide 2% Versus Autologous Serum
- Conditions
- Interventions
- First Posted Date
- 2018-08-01
- Last Posted Date
- 2018-12-04
- Lead Sponsor
- Hospital Nacional Profesor Alejandro Posadas
- Target Recruit Count
- 21
- Registration Number
- NCT03608761
- Locations
- 🇦🇷
Hospital Nacional Profesor A. Posadas, El Palomar, Buenos Aires, Argentina
A Study to Evaluate REbamiPide as an Adjuvant Regimen to Heal erosIve Reflux Esophagitis
- Conditions
- Interventions
- First Posted Date
- 2016-04-29
- Last Posted Date
- 2016-04-29
- Lead Sponsor
- YongChan Lee
- Target Recruit Count
- 143
- Registration Number
- NCT02755753
- Locations
- 🇰🇷
Soonchunhyang University Bucheon Hospital, Bucheon, Korea, Republic of
🇰🇷Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of
🇨🇳Yang Shiming, Chongqing, Chongqing, China
Clinical Effect of Rebamipide on Chronic Gastritis
- Conditions
- Interventions
- First Posted Date
- 2015-03-19
- Last Posted Date
- 2015-03-19
- Lead Sponsor
- BangMao Wang
- Target Recruit Count
- 180
- Registration Number
- NCT02393430
The Effect of Proton Pump Inhibitor and Polaprezinc Combination Therapy for Healing of Endoscopic Submucosal Dissection-induced Ulcer
- Conditions
- Interventions
- First Posted Date
- 2014-09-18
- Last Posted Date
- 2019-03-27
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 153
- Registration Number
- NCT02243618
- Locations
- 🇰🇷
Sevrance hospital, Seoul, Korea, Republic of
Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional Dyspepsia
- Conditions
- Interventions
- First Posted Date
- 2014-05-09
- Last Posted Date
- 2016-01-05
- Lead Sponsor
- University of Malaya
- Target Recruit Count
- 200
- Registration Number
- NCT02134405
- Locations
- 🇲🇾
University Malaya Medical Centre, Kuala Lumpur, Federal Territory, Malaysia
A Drug Interaction Study of Mosapride and Rebamipide
- First Posted Date
- 2014-04-08
- Last Posted Date
- 2014-04-08
- Lead Sponsor
- IlDong Pharmaceutical Co Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT02106130
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.